L&G Healthcare Technology & Innovation UCITS ETF (LON:DOCG)
London · Delayed Price · Currency is GBP · Price in GBX 1,026.20
+5.50 (0.54%)
May 1, 2026, 3:56 PM GMT
23.04% (1Y)
| Assets | 135.11M |
| Expense Ratio | 0.49% |
| PE Ratio | 25.68 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +23.04% |
| Volume | 55,923 |
| Open | 1,029.80 |
| Previous Close | 1,020.70 |
| Day's Range | 1,022.65 - 1,030.13 |
| 52-Week Low | 809.60 |
| 52-Week High | 1,195.40 |
| Beta | 0.45 |
| Holdings | 63 |
| Inception Date | Jun 17, 2019 |
About DOCG
L&G Healthcare Technology & Innovation UCITS ETF is headquartered in London, Greater London, United Kingdom.
Asset Class Equity
Category Health Care
Stock Exchange London Stock Exchange
Ticker Symbol DOCG
Provider L&G
Index Tracked ROBO Global Healthcare Technology and Innovation ETF
Performance
DOCG had a total return of 23.04% in the past year, including dividends. Since the fund's inception, the average annual return has been 3.56%.
Top 10 Holdings
22.12% of assets| Name | Symbol | Weight |
|---|---|---|
| Axogen, Inc. | AXGN | 3.15% |
| Arrowhead Pharmaceuticals, Inc. | ARWR | 2.54% |
| Twist Bioscience Corporation | TWST | 2.34% |
| Natera, Inc. | NTRA | 2.12% |
| Alnylam Pharmaceuticals, Inc. | ALNY | 2.02% |
| Thermo Fisher Scientific Inc. | TMO | 2.00% |
| Vertex Pharmaceuticals Incorporated | VRTX | 2.00% |
| Intuitive Surgical, Inc. | ISRG | 2.00% |
| Tempus AI, Inc. | TEM | 1.98% |
| Guardant Health, Inc. | GH | 1.97% |